Evidence of Th1, Th17 and Tc17 cells in psoriasiform chronic graft-versus-host disease.
INSERM and UMRS 976, Laboratory of Oncodermatology, Immunology, and Cutaneous Stem Cells, Paris, France.|University Paris Diderot, Sorbonne Paris Cité, Paris, France.|Dermatology Department, Saint-Louis Hospital, Paris, France.
François
F
Chasset
INSERM and UMRS 976, Laboratory of Oncodermatology, Immunology, and Cutaneous Stem Cells, Paris, France.|University Paris Diderot, Sorbonne Paris Cité, Paris, France.
Hélène
H
Le Buanec
University Paris Diderot, Sorbonne Paris Cité, Paris, France.|Hematology and Transplantation, Saint-Louis Hospital, Paris, France.
Flore
F
Sicre de Fontbrune
INSERM and UMRS 976, Laboratory of Oncodermatology, Immunology, and Cutaneous Stem Cells, Paris, France.|University Paris Diderot, Sorbonne Paris Cité, Paris, France.|Dermatology Department, Saint-Louis Hospital, Paris, France.
Adèle
A
de Masson
University Paris Diderot, Sorbonne Paris Cité, Paris, France.|Pathology Department, Saint Louis Hospital, Paris, France.
Jacqueline
J
Rivet
University Paris Diderot, Sorbonne Paris Cité, Paris, France.|Pneumology Department, Saint-Louis Hospital, Paris, France.
Anne
A
Bergeron
INSERM and UMRS 976, Laboratory of Oncodermatology, Immunology, and Cutaneous Stem Cells, Paris, France.|University Paris Diderot, Sorbonne Paris Cité, Paris, France.|Dermatology Department, Saint-Louis Hospital, Paris, France.
Martine
M
Bagot
University Paris Diderot, Sorbonne Paris Cité, Paris, France.|Hematology and Transplantation, Saint-Louis Hospital, Paris, France.
Gérard
G
Socié
INSERM and UMRS 976, Laboratory of Oncodermatology, Immunology, and Cutaneous Stem Cells, Paris, France.|University Paris Diderot, Sorbonne Paris Cité, Paris, France.
Armand
A
Bensussan
INSERM and UMRS 976, Laboratory of Oncodermatology, Immunology, and Cutaneous Stem Cells, Paris, France.|University Paris Diderot, Sorbonne Paris Cité, Paris, France.|Dermatology Department, Saint-Louis Hospital, Paris, France.
Jean-David
JD
Bouaziz
D015496:CD4-Positive T-Lymphocytes / Q000166:cytology; D018414:CD8-Positive T-Lymphocytes / Q000166:cytology; D006086:Graft vs Host Disease / Q000276:immunology* / Q000628:therapy; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects; D006801:Humans; D007371:Interferon-gamma / Q000378:metabolism; D016753:Interleukin-10 / Q000378:metabolism; D020381:Interleukin-17 / Q000378:metabolism*; D015603:Keratinocytes / Q000166:cytology; D008168:Lung / Q000276:immunology; D008214:Lymphocytes / Q000166:cytology; D008297:Male; D008875:Middle Aged; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000628:therapy; D011565:Psoriasis / Q000378:metabolism*; D012074:Remission Induction; D012867:Skin / Q000276:immunology / Q000473:pathology; D018417:Th1 Cells / Q000166:cytology*; D058504:Th17 Cells / Q000166:cytology*
C573415:IFNG protein, human; C508609:IL10 protein, human; C508717:IL17A protein, human; D020381:Interleukin-17; D016753:Interleukin-10; D007371:Interferon-gamma
T helper Lymphocyte 1 and 17; graft-versus-host disease; interferon-gamma; interleukin-17; psoriasis